ABSTRACT
Introduction: As the pandemic continues, SARS-CoV-2 infection has inevitably been detected in patients hospitalized for other reasons. Detection of SARS-CoV-2 infected cases after hospitalization may lead to delay in taking appropriate infection control measures. Materials and Methods: The present study retrospectively scanned all electronic and hard copy records of the cases presented to the hospital and hospitalized for other reasons and then diagnosed as COV1D-19 in Suleyman Demirel University Faculty of Medicine, Research and Training Hospital between 01 April 2020 and 31 December 2020. Results: Accordingly, 22 cases were decided as community-acquired, 3 cases as probable community-acquired, 5 cases as hospital-acquired, and 4 cases as probable hospital-acquired. The reason for sampling for SARS-CoV-2 was determined as having symptoms compatible with COVID-19 in 23 (67.6%) of 34 cases, preoperative screening of COVID-19 infection in 9 (26.5%), and high risky contact in 2 cases (5.9%). Considering contact histories epidemiologically, it was thought that transmission occurred to 8 healthcare staff from 2 cases, and to other patients or relatives from 8 cases, but sequence analysis could not be performed. Conclusion: The high number of hospitalized patients diagnosed as COVID-19 creates a significant burden on the healthcare system in terms of infrastructure and management capacity. It is recommended that patients and healthcare professionals be screened widely and thoroughly, especially in conditions where COVID-19 cases are detected in non-COVID-1 9 units. This kind of screening will allow the potential outbreak to be controlled.
ABSTRACT
Mask, social distancing, and hygiene are followed as primary precautions in order to be protected from the SARS-CoV-2 infection. At the beginning of the pandemic, the virus was considered to be transmitted by droplets and aerosols during medical procedures generating aerosolization. However, case clusters published later on proved that the virus was also transmitted by aerosols in indoors and in settings with bad ventilation. This study aimed to discuss the experimental and epidemiological data supporting aerosol transmission of SARS-CoV-2.
ABSTRACT
After emerging in Wuhan city in December 2019, the coronavirus disease 2019 (COVID-19) rapidly spread throughout China. Although high rates of hospitalization are seen with COVID-19, no specific treatment has been reported, and the choice of antiviral therapies is limited. Favipiravir, approved in Japan for influenza, is one of the drugs that targets RNA-dependent RNA polymerase (RdRP). It significantly decreases the duration of fever, cough dyspnea, and the need of oxygen therapy or noninvasive mechanical ventilation, especially in moderate COVID-19 cases. In the current paper we presented four cases with worsening clinical conditions and the development of hypoxia who were treated with Favipiravir before being admitted to the intensive care unit, and who recovered from the disease.